Careers  |  Sign In  |  Register  |   Twitter

Latest in Oncology

Bladder, lung, and skin cancer patients frequently showed evidence of high tumor mutational burden.
Magnetism is leveraged for site targeting, medicine delivery, and efficacy monitoring with this new nanoparticle technology.
The AUA has teamed up with ASCO, ASTRO, and SUO to provide new guidelines for non-metastatic MBIC treatment.